Peters W A, Bagley C M, Smith M R
Cancer. 1986 Dec 15;58(12):2625-7. doi: 10.1002/1097-0142(19861215)58:12<2625::aid-cncr2820581213>3.0.co;2-a.
CA-125 levels were determined in seven patients with a mixed mesodermal tumor of the ovary or endometrium. An elevated level was detected in five of six patients with metastatic or recurrent disease. Chemotherapy with cisplatin and Adriamycin (doxorubicin) resulted in a response in four patients, and the CA-125 level correlated well with the clinical status of the disease. Cisplatin/Adriamycin is an active combination in mixed mesodermal tumors and CA-125 appears to be a useful marker for following therapy.
对7例患有卵巢或子宫内膜混合性中胚层肿瘤的患者测定了CA - 125水平。在6例转移性或复发性疾病患者中，有5例检测到CA - 125水平升高。顺铂和阿霉素（多柔比星）化疗使4例患者产生反应，且CA - 125水平与疾病的临床状态密切相关。顺铂/阿霉素在混合性中胚层肿瘤中是一种有效的联合用药，CA - 125似乎是监测治疗效果的有用标志物。
